However, in a larger study, reduction in prevalence of gastro-intestinal complications failed to reach statistical significance in either the US or UK cohort [ 44 ].
← all excerpts
Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy.
1
—
—